MIDODRINE HYDROCHLORIDE - search results

United States - English - NLM (National Library of Medicine)

midodrine hydrochloride tablet

lifestar pharma llc - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (oh). because midodrine hydrochloride tablets can cause marked elevation of supine blood pressure (bp>200 mmhg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. the indication is based on midodrine hydrochloride tablets's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. at present, however, clinical benefits of midodrine hydrochloride tablets, principally improved ability to perform life activities, have not been established. further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets. after initiation of treatment, midodrine hydrochloride tablets should be continued only for patients who repor

United States - English - NLM (National Library of Medicine)

proamatine midodrine hydrochloride tablet

shire us manufacturing inc. - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride 2.5 mg

United States - English - NLM (National Library of Medicine)

proamatine- midodrine hydrochloride tablet

physicians total care, inc. - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride 5 mg - proamatine ® is indicated for the treatment of symptomatic orthostatic hypotension (oh). because proamatine ® can cause marked elevation of supine blood pressure (bp>200 mmhg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. the indication is based on proamatine ® 's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. at present, however, clinical benefits of proamatine ® , principally improved ability to perform life activities, have not been established. further clinical trials are underway to verify and describe the clinical benefits of proamatine ® . after initiation of treatment, proamatine ® should be continued only for patients who report significant symptomatic improvement. proamatine ® is contraindicated in patients with severe